Heba Ijaz
Impact in
-
- Hemoglobinopathies and Related Disorders
- Glioma Diagnosis and Treatment
Papers in
- Oncology 2
- PARP inhibition in cancer therapy 2
-
- Protein Degradation and Inhibitors 1
- Co-authors
- Yan Dai (1 shared paper)Martin H. Steinberg (1 shared paper)Xiaowei Liu (3 shared papers)Kristina A. Cole (3 shared papers)Charles G. Minard (3 shared papers)Stephan D. Voss (3 shared papers)Joel M. Reid (2 shared papers)Elizabeth Fox (3 shared papers)
- Journals
- American Journal of Hematology (1 paper)Clinical Cancer Research (1 paper)Cancer (1 paper)Cancer Research (1 paper)
- Partner nations
- United StatesSwitzerland
In The Last Decade
Heba Ijaz
4 papers receiving 102 citations
Peers
Comparison fields: 5 of 32
- Genetics 35
- Hematology 14
- Geriatrics and Gerontology 3
- Molecular Biology 62
- Oncology 22
Countries citing papers authored by Heba Ijaz
This map shows the geographic impact of Heba Ijaz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heba Ijaz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heba Ijaz more than expected).
Fields of papers citing papers by Heba Ijaz
This network shows the impact of papers produced by Heba Ijaz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heba Ijaz. The network helps show where Heba Ijaz may publish in the future.
Co-authors
The 17 scholars most cited alongside Heba Ijaz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 50 | |
| 2 | 2017 | 35 | |
| 3 | 2023 | 17 | |
| 4 | 2021 | 1 |
About Heba Ijaz
Heba Ijaz is a scholar working on Oncology, Molecular Biology, Genetics, Neurology and Hematology, having authored 4 papers that have together received 103 indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (2 papers), Hemoglobinopathies and Related Disorders (1 paper), Neuroblastoma Research and Treatments (1 paper), Iron Metabolism and Disorders (1 paper) and Protein Degradation and Inhibitors (1 paper). The work is most often cited by research in Genetics (35 citations), Hematology (14 citations), Geriatrics and Gerontology (3 citations), Molecular Biology (62 citations) and Oncology (22 citations). Heba Ijaz has collaborated with scholars based in United States and Switzerland. Frequent co-authors include Yan Dai, Martin H. Steinberg, Xiaowei Liu, Kristina A. Cole, Charles G. Minard, Stephan D. Voss, Joel M. Reid, Elizabeth Fox, Brenda J. Weigel and John M. Maris. Their work appears in journals such as American Journal of Hematology, Clinical Cancer Research, Cancer and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.